Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-0.03%)
As of: Oct 22, 2026 · 10:04 AM EDT

Mereo BioPharma (MREO) Other financing activities (2023 - 2025)

Updated

Mereo BioPharma (MREO) reported Other financing activities of $33,000 for FY2023.

Analysis

Mereo BioPharma (MREO) Other financing activities (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn
10 Mereo BioPharma 46.78 Mn -103.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -134,000.00
Mar 31, 2025 -65,000.00
Dec 31, 2024 -40,000.00
Sep 30, 2024 -594,000.00
Jun 30, 2024 -219,000.00
Dec 31, 2023 -511,000.00
API Access

Mereo BioPharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MREO&period=max&api_key=YOUR_API_KEY